Clinical trials
Epilepsy trials in Belgium with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 5 |
| Terminated | 4 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Ghent | 11 |
| Universitaire Ziekenhuizen KU Leuven | 6 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 3 |
| Cyberonics, Inc. | 1 |
| Hospices Civils de Lyon | 1 |
| Neuroelectrics Corporation | 1 |
| Sergiusz Jozwiak | 1 |
| UNEEG Medical A/S | 1 |
| University Ghent | 1 |
| prof. dr. Koen Van Laere | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 27 |
| Drug Resistant Epilepsy | 3 |
| Seizures | 3 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Brain Neoplasms | 1 |
| Chronic Pain | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Epilepsia Partialis Continua | 1 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.